Peer-reviewed veterinary case report
Treatment and outlook for immune-mediated anemia in dogs
By Balch, Andrea & Mackin, Andrew·Published in Compendium (Yardley, PA)·2007·Las Vegas Veterinary Referral Center, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Canine immune-mediated hemolytic anemia: treatment and prognosis.
- Species:
- dog
Plain-English summary
In dogs with a condition called immune-mediated hemolytic anemia, where the immune system mistakenly attacks red blood cells, treatment typically includes providing oxygen support for a short time and using medications to suppress the immune system over a longer period. Options for treatment may involve blood transfusions, various medications to help control the immune response, and sometimes surgery to remove the spleen, which can help prevent complications like blood clots. The article also talks about how likely dogs are to recover and what factors might influence their chances. Overall, the treatment aims to improve the dog's condition and manage symptoms effectively.
Abstract
The treatment of primary immune-mediated hemolytic anemia involves short-term oxygen-carrying support and long-term immunosuppressive therapy. Therapeutic options include blood transfusion, standard and more speculative immunosuppressive agents, splenectomy, and prevention of thromboembolic disease. This article also discusses the prognosis and prognostic indicators.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/17726852/